Oligonucleotide, capsid and nucleic acid analysis
Gene therapy research is critical to solving genetic diseases and advancing patient treatment. As the complementary fields of somatic gene therapy and cell-based therapy continue to develop rapidly, the design and commercialization of gene and cell therapies become a complex undertaking. Viral vectors are routinely utilized as a gene therapy delivery vehicle, with the quality of capsid proteins and nucleic acids integral to the safety and efficacy of this product.
A complete suite of instruments and solutions from SCIEX can help reduce some of that complexity and help you bring a safe, effective therapy to market sooner. Whether you are investigating ASOs, siRNAs, mRNAs, CRISPR, viral vector based gene therapies or cell-based therapies, SCIEX has your gene therapy research covered.
Through the precision analytics of SCIEX CE and LC-MS/MS technology, your laboratory will benefit from flexible workflows to get the answers you need when you need them most. SCIEX offers multiple kit-based chemistries to assess the quality and impurities of nucleic acids through the use of ultrasensitive fluorescence detection.
Discover ways to accelerate your gene therapy and oligonucleotide development by getting the right answers the first time, through precise analytics you can trust.